Skip to main content

Asthma Inhalers Tied to Large Greenhouse Gas Emissions Production

Medically reviewed by Carmen Pope, BPharm. Last updated on Sep 4, 2024.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Sept. 4, 2024 -- Inhaler devices are a substantial source of greenhouse gas emissions in the United States, according to a research letter published online Aug. 29 in the Journal of the American Medical Association.

Jyothi Tirumalasetty, M.D., from the Stanford University School of Medicine in California, and colleagues assessed mean emissions in 2022 for U.S. brand-name inhalers (metered-dose, dry powder, and soft-mist classes) prescribed to Medicare Part D and Medicaid beneficiaries using inhaler claims and cost data extracted from the Centers for Medicare & Medicaid Services (CMS) summary and statistics database.

The researchers found that mean estimated emissions per inhaler by device class were 23.1 kg of carbon dioxide equivalent (CO2e) for metered-dose inhalers (14 inhalers), 0.79 kg CO2e for dry-powder inhalers (19 inhalers), and 0.78 kg CO2e for soft-mist inhalers (4 inhalers), with 10 kg CO2e equivalent to 41.2 km driven in an average gasoline-powered passenger vehicle. The highest emissions per inhaler were seen for the inhaled corticosteroid, long-acting β-agonist, metered-dose inhaler Dulera (mometasone/formoterol; 48.1 kg CO2e) versus an analogous inhaled corticosteroid, long-acting β-agonist, dry-powder inhaler Advair Diskus (fluticasone/salmeterol; 0.898 kg CO2e emissions per inhaler). For short-acting β-agonist medications, Ventolin HFA (albuterol sulfate) had the highest emissions (28.7 kg CO2e per inhaler). Overall, there were 69.8 million CMS inhaler claims in 2022, resulting in an estimated 1.15 million metric tons of CO2e emissions, or the equivalent of 226,960 homes' yearly electricity use.

"Formulary choices that optimize clinical efficacy, greenhouse gas emissions, and affordability may improve patient outcomes and reduce climate pollution," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted September 2024

Read this next

Cardiorespiratory Effects of Smoke Fine Particulate Matter From Wildfires Can Persist for Months

THURSDAY, June 5, 2025 -- The cardiorespiratory effects of smoke fine particulate matter (PM2.5), a primary wildfire emission that can spike for months after a wildfire begins...

Multiple Environmental Exposures Jointly Contribute to Asthma Risk

WEDNESDAY, May 28, 2025 -- Air pollution, built environment, and ambient temperature jointly contribute to incident asthma risk, according to a study published online May 15 in...

Severe Exacerbations Down With As-Needed Albuterol-Budesonide for Mild Asthma

FRIDAY, May 23, 2025 -- As-needed albuterol-budesonide yields a lower risk for severe asthma exacerbation among patients with mild asthma, according to a study published online...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.